Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.80
Bid: 361.60
Ask: 362.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.111%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 362.80
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

6 Feb 2024 11:55

RNS Number : 2050C
QinetiQ Group plc
06 February 2024
 

QINETIQ GROUP PLC

6 February 2024

QINETIQ GROUP PLC

Results of General Meeting held on 6 February 2024

Poll Results of General Meeting

QinetiQ Group plc (QinetiQ) announces that the resolution proposed as an ordinary resolution at its General Meeting (GM) held on 6 February 2024 was duly passed without amendment by the requisite majority of shareholders and the results of the poll are as follows:

VOTES FOR

%

VOTES AGAINST

%

TOTAL VOTES VALIDLY CAST

% OF SHARE CAPITAL WITH VOTING RIGHTS

VOTES WITHHELD

1

To authorise the Company to make market purchases of its ordinary shares pursuant to section 701 of the Companies Act 2006

485,836,928

99.51

2,371,173

0.49

488,208,101

84.35

688,113

Notes:

1. The percentages above are rounded to two decimal places.

2. Votes "for" include discretionary votes.

3. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

4. The number of ordinary shares in issue at 6.30pm on 2 February 2024 was 578,757,121 of which none are held in treasury. Therefore the number of ordinary shares with voting rights at 6.30pm on 2 February 2024 was 578,757,121.

Results of the poll can also be viewed on QinetiQ's website: https://www.qinetiq.com/en/investors/shareholder-services/agm

Following the resolution being duly passed, the share buyback programme as previously announced on 16 January 2024 (the Programme) will commence on 7 February 2024.

The first tranche of up to £50 million will be carried out through an irrevocable non-discretionary agreement with Barclays Capital Securities Limited (Barclays) on the basis set out in the announcement of the Programme on 16 January 2024. Barclays may undertake transactions in QinetiQ shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or an over the counter basis) during the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by Barclays as a result of or part of the Programme, but Barclays will continue to make any disclosures they are otherwise legally required to make.

In accordance with Listing Rule 9.6.2, a copy of the resolution will be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

John Haworth, Group Director Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFELFFIRIIS
Date   Source Headline
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20249:32 amRNSHolding(s) in Company
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 202411:55 amRNSResult of Meeting
5th Feb 20243:48 pmRNSDirector/PDMR Shareholding
19th Jan 20249:31 amRNSDirector/PDMR Shareholding
16th Jan 20247:00 amRNSQ3 Trading Update and Share Buyback Programme
10th Jan 20245:00 pmRNSDirector/PDMR Shareholding
12th Dec 20232:38 pmRNSDirector/PDMR Shareholding
12th Dec 20232:32 pmRNSDirector Declaration
22nd Nov 20238:29 amRNSHolding(s) in Company
20th Nov 20237:00 amRNS$170m US new business contract win
16th Nov 20237:00 amRNSInterim Results
13th Nov 20239:58 amRNSDirector/PDMR Shareholding
25th Oct 20237:23 amRNSInvestor Seminar
17th Oct 20238:00 amRNSDirector Declaration
11th Oct 20237:00 amRNSSecond Quarter Trading Update
10th Oct 20233:56 pmRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNS$127m contract win in the US (formerly Avantus)
3rd Oct 20237:00 amRNS$84m contract win in the US
28th Sep 20233:24 pmRNSDirector/PDMR Shareholding
12th Sep 20235:54 pmRNSDirector/PDMR Shareholding
31st Aug 20235:03 pmRNS$224m contract win in the US (formerly Avantus)
25th Aug 20232:23 pmRNSDirector/PDMR Shareholding
10th Aug 20234:31 pmRNSDirector/PDMR Shareholding
27th Jul 20234:45 pmRNSDirector/PDMR Shareholding
20th Jul 20232:00 pmRNSResult of AGM
20th Jul 20237:00 amRNSFirst Quarter Trading Update
11th Jul 20235:30 pmRNSDirector/PDMR Shareholding
21st Jun 202312:15 pmRNSDirector/PDMR Shareholding
14th Jun 202310:00 amRNSHolding(s) in Company
12th Jun 20234:00 pmRNSDirector/PDMR Shareholding
12th Jun 20232:00 pmRNSAnnual Financial Report
25th May 20237:00 amRNSResults for the year ended 31 March 2023
10th May 20234:55 pmRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSFourth Quarter Trading Update
12th Apr 202311:35 amRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSQinetiQ announces £259 million renewal of MSCA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.